<?xml version="1.0" encoding="UTF-8"?>
<ref id="B53">
 <label>53.</label>
 <mixed-citation publication-type="webpage">
  <person-group person-group-type="author">
   <collab>Gilead</collab>
  </person-group>
  <source>Gilead Announces Results From Phase 3 Trial of Investigational Antiviral Remdesivir in Patients With Severe COVID-19</source>. (
  <year>2020</year>). Available online at: 
  <ext-link ext-link-type="uri" xlink:href="https://www.gilead.com/news-and-press/" xmlns:xlink="http://www.w3.org/1999/xlink">https://www.gilead.com/news-and-press/</ext-link> (accessed April 20, 2020).
 </mixed-citation>
</ref>
